High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for recurrent medulloblastoma

被引:0
|
作者
Dunkel, I
Gardner, S
Garvin, J
Goldman, S
Shi, WJ
Finlay, J
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NYU Med Ctr, New York, NY 10016 USA
[3] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[4] Childrens Mem Hosp, Chicago, IL 60614 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:453 / 453
页数:1
相关论文
共 50 条
  • [21] High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors
    Pérez-Martínez, A
    Lassaletta, A
    González-Vicent, M
    Sevilla, J
    Díaz, MA
    Madero, L
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2005, 71 (01) : 33 - 38
  • [22] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Franca Falzetti
    Mauro Di Ianni
    Stelvio Ballanti
    Giuseppe Iodice
    Antonia Reale
    Olivia Minelli
    Gabriella Serio
    Massimo F. Martelli
    Franco Dammacco
    Angelo Vacca
    Roberto Ria
    [J]. Clinical and Experimental Medicine, 2012, 12 : 165 - 171
  • [23] Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
    Agaliotis, DP
    Ballester, OF
    Mattox, T
    Hiemenz, JW
    Fields, KK
    Zorsky, PE
    Goldstein, SC
    Perkins, JB
    Rosen, RM
    Elfenbein, GJ
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05): : 292 - 298
  • [24] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Falzetti, Franca
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 12 (03) : 165 - 171
  • [25] Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors
    Finlay, JL
    Goldman, S
    Wong, MC
    Cairo, M
    Garvin, J
    August, C
    Cohen, BH
    Stanley, P
    Zimmerman, RA
    Bostrom, B
    Geyer, JR
    Harris, RE
    Sanders, J
    Yates, AJ
    Boyett, JM
    Packer, RJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) : 2495 - 2503
  • [26] Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors
    Modak, S
    Gardner, S
    Dunkel, IJ
    Balmaceda, C
    Rosenblum, MK
    Miller, DC
    Halpern, S
    Finlay, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1934 - 1943
  • [27] High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma
    Dunkel, IJ
    Finlay, JL
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1996, 29 (01) : 69 - 74
  • [28] Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support
    Lotz, JP
    Izrael, V
    [J]. BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 858 - 859
  • [29] CUTANEOUS TOXICITY OF HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION
    BEYER, J
    GRABBE, J
    LENZ, K
    WEISBACH, V
    STROHSCHEER, I
    HUHN, D
    SIEGERT, W
    [J]. BONE MARROW TRANSPLANTATION, 1992, 10 (06) : 491 - 494
  • [30] High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma
    Hong, C. R.
    Kang, H. J.
    Kim, M. S.
    Ju, H. Y.
    Lee, J. W.
    Kim, H.
    Kim, H-S
    Park, S-H
    Park, K. D.
    Park, J. D.
    Shin, H. Y.
    Ahn, H. S.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 (10) : 1375 - 1378